Reply to Walker et al.
Reply to Walker et al.
复制标题
回复沃克等人。
DOI:
10.1093/cid/cit099
复制
发表时间:
2013
期刊:
影响因子:
--
通讯作者:
Aronoff,DavidM
中科院分区:
文献类型:
--
作者:
Walk,SethT;Micic,Dejan;Galecki,AndrzejT;Rogers,MaryAM;Washer,Laraine;Newton,DuaneW;Malani,PreetiN;Young,VincentB;Aronoff,DavidM
TO THE EDITOR—We thank Walker et al for their interest in our work [1]. Our study found no evidence of difference in clinical severity of Clostridium difficile infection (CDI) between patients infected with ribotype 027/078 strains compared with others, when adjusted for other covariates [2]. Adjustment for factors on the hypothesized causal pathway between exposure (ribotype) and outcome (severity), such as leukocyte count, has been addressed elsewhere [3]. Removing the leukocyte count as a covariate or including it in the definition of severe disease did not alter our findings [3]. We appreciate the concern regarding the fact that the resultant P values were close to the standard α level of. 05. We used the customary cut-point for α found in the scientific literature but appreciate its limitations. It is possible, with more patients, that an association may be found. However, a secondary analysis of our entire dataset (Supplementary Table 1 [2]) was conducted with a total of 413 CDI cases. The association between ribotype 027/078 and severe disease in this analysis yielded an odds ratio of 1.34 (95% confidence interval,. 67–2.58) when only adjusted for age, sex, and CDI surveillance definition—factors that existed prior to CDI diagnosis.